Tandem Diabetes plans $60 million public offering of common stock

BofA Merrill Lynch, Piper Jaffray, Deutsche Bank and Stifel to assist

By Devika Patel

Knoxville, Tenn., Feb. 24 – Tandem Diabetes Care, Inc. will raise $60 million in a public offering of common stock with a 30-day greenshoe option, according to a prospectus supplement filed Tuesday with the Securities and Exchange Commission.

BofA Merrill Lynch and Piper Jaffray are the bookrunning managers. Deutsche Bank Securities and Stifel are the co-managers.

Proceeds will be used for working capital and other general corporate purposes.

The medical device company is based in San Diego.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.